|1.||Grant, P J: 1 article (06/2010)|
|2.||Booth, N A: 1 article (06/2010)|
|3.||Connolly, T M: 1 article (06/2010)|
|4.||Feuerstein, G Z: 1 article (06/2010)|
|5.||Fraser, S: 1 article (06/2010)|
|6.||Newby, D E: 1 article (06/2010)|
|7.||Gardell, S J: 1 article (06/2010)|
|8.||Lucking, A J: 1 article (06/2010)|
|9.||Philippou, H: 1 article (06/2010)|
|10.||Visvanathan, A: 1 article (06/2010)|
06/01/2010 - "Despite its efficacy in a purified human system and in preclinical models of thrombosis, the current study suggests that PAI-749 does not affect thrombus formation or fibrinolysis in a range of established human plasma and whole blood-based systems."
06/01/2010 - "PAI-749 had no effect on in vitro or ex vivo thrombus formation or fibrinolysis in the presence or absence of t-PA. "
06/01/2010 - "To assess the effect of PAI-749, by using an established ex vivo clinical model of thrombosis and a range of complementary in vitro human plasma-based and whole blood-based models of fibrinolysis. "
06/01/2010 - "In a double-blind, randomized, crossover study, ex vivo thrombus formation was assessed using the Badimon chamber in 12 healthy volunteers during extracorporeal administration of tissue-type plasminogen activator (t-PA) in the presence of PAI-749 or control. "
|1.||Tissue Plasminogen Activator (Alteplase)